Former Senior Manager of Scientific Communications at Sepracor Inc. in Marlborough, Massachusetts, Elizabeth Goodwin utilized her scientific knowledge and communication skills to produce a variety of company publications. Primarily, Elizabeth Goodwin was responsible for conceptualizing and carrying out communication plans for some of Sepracor Inc.'s most important pharmaceuticals. The plans had a three-year execution timeline and included the drugs Xopenex, Brovana, and Alvesco. Xopenex and Brovana were created to help those suffering from lung diseases and disorders, such as asthma and chronic obstructive pulmonary disease, while Alvesco is a nasal spray that treats allergic rhinitis. Another aspect of Elizabeth Goodwin’s position at Sepracor Inc. was her creation of manuscripts detailing the clinical trial results of various new pharmaceuticals. This process included examining clinical trial details as well as heading meetings that review them. After generating these manuscripts, Elizabeth Goodwin presented her findings at the International Scientific Congress. Over the course of her four years at the company, Elizabeth Goodwin consistently exceeded the expectations of her superiors and her peers. Her adept problem solving skills, ability to work well with a team, and her proficiency at managing and completing projects earned her numerous Ovation awards. Elizabeth Goodwin’s accomplishments include co-authoring 31 scientific manuscripts for peer review journals. She has also created and published 50 abstracts and 25 manuscripts related to her work at Sepracor Inc. A member of the third, fourth, and fifth Center for Business Intelligence Annual Forums on Strategic Publication Planning, Elizabeth Goodwin has also taken Post-graduate classes at the American Thoracic Society and participated in the Epilepsy Therapy Project in Boston, Massachusetts. In her free time, Elizabeth Goodwin volunteers and enjoys spending time with her horse and dogs.